CASM - CAS Medical Systems, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
-0.08 (-4.15%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close1.93
Bid0.01 x 1000
Ask1.85 x 800
Day's Range1.72 - 1.93
52 Week Range0.59 - 2.70
Avg. Volume67,026
Market Cap51.548M
Beta (3Y Monthly)1.15
PE Ratio (TTM)N/A
EPS (TTM)-0.12
Earnings DateNov 7, 2018 - Nov 12, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.00
Trade prices are not sourced from all markets
  • GlobeNewswire6 days ago

    New Research Coverage Highlights CAS Medical, Saia, Core Laboratories N.V, Perceptron, CRISPR Therapeutics AG, and IEC Electronics — Consolidated Revenues, Company Growth, and Expectations for 2018

    NEW YORK, Nov. 13, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • A Look At The Fair Value Of CAS Medical Systems Inc (NASDAQ:CASM)
    Simply Wall St.6 days ago

    A Look At The Fair Value Of CAS Medical Systems Inc (NASDAQ:CASM)

    In this article I am going to calculate the intrinsic value of CAS Medical Systems Inc (NASDAQ:CASM) by estimating the company’s future cash flows and discounting them to their present Read More...

  • Thomson Reuters StreetEvents12 days ago

    Edited Transcript of CASM earnings conference call or presentation 31-Oct-18 2:00pm GMT

    Q3 2018 CAS Medical Systems Inc Earnings Call

  • Zacks Small Cap Research13 days ago

    CASM: Competitive Wins Resulting in Accelerating Consumable Revenue, Rapidly Improving Profitability

    Another solid quarter turned in by CAS Medical (CASM) with total revenue jumping 19% yoy and about 2% better than Q2. The combination of revenue growth and effective expense-control initiatives have pushed operating loss lower by an average of ~$150k each quarter since Q1 2017. Importantly, despite the recently instituted trade tariffs, management is guiding for reaching cash flow break even by the end of 2019 (and possibly sooner if the tariffs are lifted).

  • GlobeNewswire19 days ago

    CASMED Reports Third-Quarter 2018 Financial Results

    FORE-SIGHT® sales increase 20%; sensor sales up 22% on 20% growth in the U.S.; operating loss narrows by 25% Conference Call Begins at 10:00 a.m. Eastern Time Today BRANFORD,.

  • GlobeNewswire26 days ago

    CASMED to Report Third-Quarter 2018 Financial Results and Hold Conference Call on October 31

    BRANFORD, Conn., Oct. 24, 2018 -- CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will.

  • Investopedia3 months ago

    Penny Stocks to Watch for September 2018

    Junior miners turned lower in sympathy with declining gold and silver contracts, while small biotech and medical diagnostic stocks picked up the slack, underpinned by sector funds probing new highs. September has a mixed reputation when it comes to small speculative plays, suggesting that traders focus their attention on penny stocks exhibiting the highest relative strength while avoiding falling knives that may face tax selling pressure in the fourth quarter. Low-priced energy stocks look like wild cards in this equation, with crude oil coming off lows while rising Middle East tensions add to sector buying power.

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of CASM earnings conference call or presentation 2-Aug-18 2:00pm GMT

    Q2 2018 CAS Medical Systems Inc Earnings Call

  • Zacks Small Cap Research3 months ago

    CASM: FORE-SIGHT Momentum Continues, Moving PT to $4.50/share

    The FORE-SIGHT business, particularly as it relates to the U.S. market, continues to impress. The U.S. installed base expanded by 25% yoy during the first half of 2018 and domestic sensor sales have now set new record highs for three consecutive quarters. U.S. FORE-SIGHT revenue grew by an average of 20% yoy over the last three quarters (including 20% in Q2).

  • ACCESSWIRE4 months ago

    CAS Medical Systems, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 2, 2018 / CAS Medical Systems, Inc. (NASDAQ: CASM ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 2, 2018 at 10:00 AM Eastern ...

  • Investopedia4 months ago

    Penny Stocks to Watch for August 2018

    Penny stock pickers booked modest returns in these tough conditions, while trend followers and dart throwers took losses. The July penny stock list generated mixed returns, with precious metals and biotech headwinds limiting gains while a mid-month crude oil reversal undermined small energy plays.

  • ACCESSWIRE5 months ago

    Wired News - Halyard Health to Buy CoolSystems; Marketed as Game Ready(R)

    LONDON, UK / ACCESSWIRE / June 7, 2018 / If you want access to our free research report on Halyard Health, Inc. (NYSE: HYH), all you need to do is sign up now by clicking the following link as the Company's latest news hit the wire. On June 05, 2018, the Company announced that it has inked a deal to acquire CoolSystems, Inc., marketed as Game Ready®, a market-leading provider of cold therapy and compression therapy systems for a total consideration of $65 million in cash. is currently working on the research report for CAS Medical Systems, Inc. (NASDAQ: CASM), which also belongs to the Healthcare sector as the Company Halyard Health.

  • Zacks Small Cap Research6 months ago

    CASM: Q1: FORE-SIGHT Revenue Jumps 20% in Q1. Sensors Sales Accelerating. Moving PT to $4.00/share

    CAS Medical (CASM) reported financial results for Q1 2018. It was an extraordinarily strong showing across their FORE-SIGHT franchise with sensors revenue in both the U.S. and international markets jumping double-digits yoy, pushing total sensors sales almost 10% higher than their prior record (in Q4 ’17). Meanwhile, monitor shipments continue to trend higher - 72 shipped in the U.S., which is the second highest level on-record (80 shipped in Q4 ’17) and 39 OUS, which is the highest since Q4 ’16.

  • Zacks Small Cap Research8 months ago

    CASM: Q4 2017 Financial Results: Record Revenue, Lowest Op Loss. Momentum Expected to Continue

    CAS Medical (CASM) reported financial results for Q4 2017, which saw revenue well ahead of our pre-preliminary announcement numbers (CASM pre-announced Q4 in early January). Strength in the U.S. market, which has been attributed to a combination of catalysts, more than offset a double-digit decline in international sales and pushed total FORE-SIGHT revenue to an all-time high. Indications, which includes 2018 guidance of low-teens percentage increase in U.S. FORE-SIGHT revenue, are that this momentum will continue, and potentially accelerate.

  • Thomson Reuters StreetEvents8 months ago

    Edited Transcript of CASM earnings conference call or presentation 14-Mar-18 2:00pm GMT

    Q4 2017 CAS Medical Systems Inc Earnings Call

  • What does CAS Medical Systems Inc’s (NASDAQ:CASM) Balance Sheet Tell Us About Its Future?
    Simply Wall St.9 months ago

    What does CAS Medical Systems Inc’s (NASDAQ:CASM) Balance Sheet Tell Us About Its Future?

    CAS Medical Systems Inc (NASDAQ:CASM) is a small-cap stock with a market capitalization of US$31.44M. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies,Read More...